Endologix Inc. (NASDAQ:ELGX) plummeted -1.89 percent and ended the day at $6.76. The Average Volume of the company is 2.26 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.

Canaccord Genuity Downgrade its coverage for Endologix Inc. (NASDAQ:ELGX) in a note sent to investors on 17-Nov-16. The research firm Downgrade the stock to Hold. Moreover, JP Morgan issued Downgrade rating for the stock on 16-Nov-16. Leerink Partners also Initiated the company to Mkt Perform on 6-Sep-16, 2016. Additionally, RBC Capital Mkts Downgrade its ratings on the stock to Sector Perform.

The highest price ELGX stock touched in the last 12 month was $14.5 and the lowest price it hit in the same period was $4.78. The stock has a Return on Assets of -38.5 percent, Return on Investment of -16.1 percent and a Return on Equity of -112.4 percent. The company’s market cap is $558.99 Million.

Price Target is an important factor while doing analysis of a stock. According to 10 analysts, Price Target for Endologix Inc. (NASDAQ:ELGX) may hit a high of $10. The average and low price target for the stock are $8.23 and $6.3, respectively.

Now we look at the Moving Averages, the 200-day is -35.79, the 50-day is 3.4 and the 20-day is 0.21. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

Looking forward, the company is expected to report earnings of $-0.23 per share for the current quarter. Revenue is expected in between 50 Million and 47.9 Million with an average of 48.69 Million.

When we look at the recommendation trends, the stock presently has an average brokerage recommendation of 0. Out of 0 brokerage recommendations, 0 gave a Strong Buy, 0 issued a Buy, 0 issued Hold, 0 rated Under-perform and 0 issued a Sell.

Endologix Inc. (NASDAQ:ELGX) performance during the last one year Degraded -8.4 percent, while its year to date (YTD) performance showed a Positive trend of 18.18 percent. The stock Fell -42.95 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -13.55 percent, whereas its last one month trend is Optimistic with 9.21 percent. Its weekly performance showed downward trend of -2.03 percent.

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at -78.5 percent, operating profit margin was -51.2 percent, whereas gross profit margin stands at 63.9 percent. Beta factor was calculated at 0.87.

Endologix Inc. (NASDAQ:ELGX) has 84.22 Million shares outstanding and 80.67 Million shares were floated in market. The short ratio in the company’s stock is documented at 8.9 and the short float is around of 24.94%. The stock’s average true range of stands at 0.3, while the relative strength index is 48.97.

Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 1.7, current ratio was 2.5, LT Debt/Equity ratio was 1.31 and Total Debt/Equity ratio was 1.31.